Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Lausanne, 21. November 2006 - Das Nestlé-Forschungszentrum (Nestlé Research Center - "NRC") und die EPFL (eine der beiden Eidgenössischen Technischen Hoch¬schulen) unterzeichneten heute ein...
-
Lausanne, le 21 novembre 2006 - Le Centre de Recherche Nestlé (CRN) et l'École polytechnique fédérale de Lausanne (EPFL) ont signé aujourd'hui un accord de recherche de cinq ans portant sur...
-
Lausanne, 21 November 2006 - The Nestlé Research Center (NRC) and EPFL (one of the two Swiss Federal Institutes of Technology) today signed a five-year agreement to conduct research on the...
-
Committee for Medicinal Products for Human Use (CHMP) issues negative opinion on 2005 Mycograb submission by NeuTec, which was acquired by Novartis in mid-2006 CHMP concluded that Mycograb...
-
Positive recommendation from the European Union's Committee for Medicinal Products for Human Use (CHMP) comes just nine months after submission Lucentis the first drug to improve vision...
-
Exforge delivers strong blood pressure reductions, even up to 43 mmHg in patients with moderate-to-severe hypertension Exforge combines complementary actions of valsartan and amlodipine - two of...
-
Data Presented at the 3rd International Scientific Friedreich's Ataxia Conference Bethesda, Maryland, USA, and Liestal, Switzerland - The US National Institute of Neurological Disorders and...
-
For release content, please refer to the attachment....
-
Substantial new short- and long-term data being submitted to US Food and Drug Administration (FDA) Novartis committed to working closely with the FDA to gain approval for Galvus, which has...
-
Horgen, 13 November 2006 - A lower order intake in the 2nd half accelerates the implementation of the Asia strategy communicated in spring 2005 which entails relocating part of capacity to the...